BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Uterine cancer AND ETV6, TEL/ABL, 2120, ENSG00000139083, P41212, TEL
30 results:

  • 1. HPV DNA Testing and Mobile Colposcopy for Cervical Precancer Screening in HIV Positive Women: A Comparison Between Two Settings in Ghana and Recommendation for Screening.
    Effah K; Anthony R; Tekpor E; Amuah JE; Wormenor CM; Tay G; Kraa SEY; Katso AM; Akonnor CA; Kemawor S; Danyo S; Atuguba BH; Essel NOM; Akakpo PK
    Cancer Control; 2024; 31():10732748241244678. PubMed ID: 38563112
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Global impact and cost-effectiveness of one-dose versus two-dose human papillomavirus vaccination schedules: a comparative modelling analysis.
    Prem K; Choi YH; Bénard É; Burger EA; Hadley L; Laprise JF; Regan MC; Drolet M; Sy S; Abbas K; Portnoy A; Kim JJ; Brisson M; Jit M
    BMC Med; 2023 Aug; 21(1):313. PubMed ID: 37635227
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Failure to follow up abnormal test results associated with cervical cancer in primary and ambulatory care: a systematic review.
    Martinez-Gutierrez J; Chima S; Boyd L; Sherwani A; Drosdowsky A; Karnchanachari N; Luong V; Reece JC; Emery J
    BMC Cancer; 2023 Jul; 23(1):653. PubMed ID: 37438686
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. High expression of folate receptor alpha is associated with poor prognosis in patients with cervical cancer.
    Yazaki S; Kojima Y; Yoshida H; Takamizawa S; Kitadai R; Nishikawa T; Shimoi T; Sudo K; Saito A; Okuma HS; Tanioka M; Noguchi E; Uno M; Ishikawa M; Kato T; Fujiwara Y; Ohe Y; Yonemori K
    J Gynecol Oncol; 2022 Nov; 33(6):e82. PubMed ID: 36245230
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Modelling cervical cancer elimination using single-visit screening and treatment strategies in the context of high HIV prevalence: estimates for KwaZulu-Natal, South Africa.
    Rao DW; Bayer CJ; Liu G; Chikandiwa A; Sharma M; Hathaway CL; Tan N; Mugo N; Barnabas RV
    J Int AIDS Soc; 2022 Oct; 25(10):e26021. PubMed ID: 36225139
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Understanding the public health value and defining preferred product characteristics for therapeutic human papillomavirus (HPV) vaccines: World Health Organization consultations, October 2021-March 2022.
    Prudden HJ; Achilles SL; Schocken C; Broutet N; Canfell K; Akaba H; Basu P; Bhatla N; Chirenje ZM; Delany-Moretlwe S; Denny L; Gamage DG; Herrero R; Hutubessy R; Villa LL; Murillo R; Schiller JT; Stanley M; Temmerman M; Zhao F; Ogilvie G; Kaslow DC; Dull P; Gottlieb SL;
    Vaccine; 2022 Sep; 40(41):5843-5855. PubMed ID: 36008233
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Now or later: Health impacts of delaying single-dose HPV vaccine implementation in a high-burden setting.
    Burger EA; Laprise JF; Sy S; Regan MC; Prem K; Jit M; Brisson M; Kim JJ
    Int J Cancer; 2022 Nov; 151(10):1804-1809. PubMed ID: 35512109
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. How challenging could be preoperative and intraoperative diagnosis of endometrial cancer?
    Ferrero A; Attianese D; Villa M; Ravarino N; Menato G; Volpi E
    Minerva Obstet Gynecol; 2023 Aug; 75(4):365-370. PubMed ID: 35191637
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Modelling the impact of prevention strategies on cervical cancer incidence in South Africa.
    van Schalkwyk C; Moodley J; Welte A; Johnson LF
    Int J Cancer; 2021 Oct; 149(8):1564-1575. PubMed ID: 34164807
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Distinct microRNA profiles for complete hydatidiform moles at risk of malignant progression.
    Lin LH; Maestá I; St Laurent JD; Hasselblatt KT; Horowitz NS; Goldstein DP; Quade BJ; Sun SY; Braga A; Fisher RA; Berkowitz RS; Elias KM
    Am J Obstet Gynecol; 2021 Apr; 224(4):372.e1-372.e30. PubMed ID: 33031755
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. NTRK-rearranged mesenchymal tumours: diagnostic challenges, morphological patterns and proposed testing algorithm.
    Wong DD; Vargas AC; Bonar F; Maclean F; Kattampallil J; Stewart C; Sulaiman B; Santos L; Gill AJ
    Pathology; 2020 Jun; 52(4):401-409. PubMed ID: 32278476
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. [Comparison of progression-free and overall survival between endometrial cancer patients treated with laparoscopic and open surgical techniques].
    Póka R; Baradács I
    Orv Hetil; 2020 Mar; 161(10):382-388. PubMed ID: 32115990
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Mortality impact of achieving WHO cervical cancer elimination targets: a comparative modelling analysis in 78 low-income and lower-middle-income countries.
    Canfell K; Kim JJ; Brisson M; Keane A; Simms KT; Caruana M; Burger EA; Martin D; Nguyen DTN; Bénard É; Sy S; Regan C; Drolet M; Gingras G; Laprise JF; Torode J; Smith MA; Fidarova E; Trapani D; Bray F; Ilbawi A; Broutet N; Hutubessy R
    Lancet; 2020 Feb; 395(10224):591-603. PubMed ID: 32007142
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Chromatin-informed inference of transcriptional programs in gynecologic and basal breast cancers.
    Osmanbeyoglu HU; Shimizu F; Rynne-Vidal A; Alonso-Curbelo D; Chen HA; Wen HY; Yeung TL; Jelinic P; Razavi P; Lowe SW; Mok SC; Chiosis G; Levine DA; Leslie CS
    Nat Commun; 2019 Sep; 10(1):4369. PubMed ID: 31554806
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. CRKL regulates alternative splicing of cancer-related genes in cervical cancer samples and HeLa cell.
    Song Q; Yi F; Zhang Y; Jun Li DK; Wei Y; Yu H; Zhang Y
    BMC Cancer; 2019 May; 19(1):499. PubMed ID: 31133010
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Protocol for the study of cervical cancer screening technologies in HIV-infected women living in Rwanda.
    Murenzi G; Dusingize JC; Rurangwa T; Sinayobye JD; Munyaneza A; Murangwa A; Zawadi T; Hebert T; Mugenzi P; Adedimeji A; Mutesa L; Anastos K; Castle PE
    BMJ Open; 2018 Aug; 8(8):e020432. PubMed ID: 30082342
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Anaplastic lymphoma kinase-negative uterine inflammatory myofibroblastic tumor containing the etv6-NTRK3 fusion gene: a case report.
    Takahashi A; Kurosawa M; Uemura M; Kitazawa J; Hayashi Y
    J Int Med Res; 2018 Aug; 46(8):3498-3503. PubMed ID: 29900760
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Hormone replacement therapy after treatment for cervical cancer: Are we adhering to standard of care?
    Rauh LA; Pannone AF; Cantrell LA
    Gynecol Oncol; 2017 Dec; 147(3):597-600. PubMed ID: 28923411
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Prise en charge des fibromes utérins en présence d'une infertilité autrement inexpliquée.
    Carranza-Mamane B; Havelock J; Hemmings R
    J Obstet Gynaecol Can; 2016 Dec; 38(12S):S597-S608. PubMed ID: 28063569
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Soluble telmisartan bearing poly (ethylene glycol) conjugated chitosan nanoparticles augmented drug delivery, cytotoxicity, apoptosis and cellular uptake in human cervical cancer cells.
    Sharma A; Jyoti K; Bansal V; Jain UK; Bhushan B; Madan J
    Mater Sci Eng C Mater Biol Appl; 2017 Mar; 72():69-76. PubMed ID: 28024639
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.